{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:58:04Z","timestamp":1791478684398,"version":"4.3.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"DOI":"10.1007\/s00464-026-13505-x","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:36:17Z","timestamp":1791477377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of semaglutide initiated six months after laparoscopic sleeve gastrectomy on long-term weight loss and metabolic outcomes: single-center preliminary study"],"prefix":"10.1007","author":[{"given":"Pamela","family":"Jeske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Roleder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Zastawna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Krokowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4020-648X","authenticated-orcid":false,"given":"Krzysztof","family":"Szmyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"13505_CR1","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2024) Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403(10431):1027\u20131050."},{"issue":"10287","key":"13505_CR2","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/S0140-6736(21)00591-2","volume":"397","author":"NL Syn","year":"2021","unstructured":"Syn NL, Cummings DE, Wang LZ, Lin DJ, Zhao JJ, Loh M, Koh ZJ, Chew CA, Loo YE, Tai BC, Kim G, So JB, Kaplan LM, Dixon JB, Shabbir A (2021) Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174\u2009772 participants. Lancet 397(10287):1830\u20131841","journal-title":"Lancet"},{"issue":"11","key":"13505_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF, STEP 1 Study Group (2021) Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 384(11):989\u20131002","journal-title":"N Engl J Med"},{"issue":"6","key":"13505_CR4","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/oby.22794","volume":"28","author":"RF Kushner","year":"2020","unstructured":"Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B, Lingvay I, Thomsen M, Wadden TA, Wharton S, Wilding JPH, Rubino D (2020) Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5. Obesity Silver Spring 28(6):1050\u20131061","journal-title":"Obesity Silver Spring"},{"issue":"4","key":"13505_CR5","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s11695-024-07137-0","volume":"34","author":"M Jamal","year":"2024","unstructured":"Jamal M, Alhashemi M, Dsouza C, Al-Hassani S, Qasem W, Almazeedi S, Al-Sabah S (2024) Semaglutide and tirzepatide for the management of weight recurrence after sleeve gastrectomy: a retrospective cohort study. Obes Surg 34(4):1324\u20131332","journal-title":"Obes Surg"},{"issue":"11","key":"13505_CR6","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/oby.70006","volume":"33","author":"M He","year":"2025","unstructured":"He M, Wang Y, Hua R, Cao C, Xu B, Shen Q, Fu X, Shao Y, Yao Q (2025) Short-term weight loss outcomes of 1.0 mg semaglutide therapy initiated 6 months after sleeve gastrectomy. Obesity Silver Spring 33(11):2067\u20132075","journal-title":"Obesity Silver Spring"},{"issue":"10","key":"13505_CR7","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1007\/s11695-022-06211-9","volume":"32","author":"A Lautenbach","year":"2022","unstructured":"Lautenbach A, Wernecke M, Huber TB, Stoll F, Wagner J, Meyh\u00f6fer SM, Meyh\u00f6fer S, Aberle J (2022) The potential of semaglutide once-weekly in patients without type 2 diabetes with weight regain or insufficient weight loss after bariatric surgery-a retrospective analysis. Obes Surg 32(10):3280\u20133288","journal-title":"Obes Surg"},{"issue":"3","key":"13505_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11892-023-01498-z","volume":"23","author":"SF Noria","year":"2023","unstructured":"Noria SF, Shelby RD, Atkins KD, Nguyen NT, Gadde KM (2023) Weight regain after bariatric surgery: scope of the problem, causes, prevention, and treatment. Curr Diab Rep 23(3):31\u201342","journal-title":"Curr Diab Rep"},{"issue":"7","key":"13505_CR9","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1038\/s41591-026-04416-4","volume":"32","author":"C Stanley","year":"2026","unstructured":"Stanley C, Mallik R, Hamid N, Jassil FC, Reuven V, Ruwona T, Dicken SJ, Qamar S, Norton B, Kingett H, Pucci A, Magee C, Boniface D, Batterham RL, Devalia K, Mok J, Elkalaawy M, Loy J, Jenkinson A, Markakis H, Adamo M, Brown A, Makaronidis J (2026) Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial. Nat Med 32(7):2662\u20132672","journal-title":"Nat Med"},{"issue":"24","key":"13505_CR10","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Torn\u00f8e CW, Ryan DH, SELECT Trial Investigators (2023) Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med 389(24):2221\u20132232","journal-title":"N Engl J Med"},{"issue":"3","key":"13505_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/jcm12030772","volume":"12","author":"C Kennedy","year":"2023","unstructured":"Kennedy C, Hayes P, Salama S, Hennessy M, Fogacci F (2023) The effect of semaglutide on blood pressure in patients without diabetes: a systematic review and meta-analysis. J Clin Med 12(3):772","journal-title":"J Clin Med"},{"issue":"2","key":"13505_CR12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/dom.14890","volume":"25","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Bhatta M, Davies M, Deanfield JE, Garvey WT, Khalid U, Kushner R, Rubino DM, Zeuthen N, Verma S (2023) Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses. Diabetes Obes Metab 25(2):468\u2013478","journal-title":"Diabetes Obes Metab"},{"key":"13505_CR13","doi-asserted-by":"publisher","first-page":"103464","DOI":"10.1016\/j.eclinm.2025.103464","volume":"88","author":"J Chu","year":"2025","unstructured":"Chu J, Zhang H, Wu Y, Huang Y, Zhu T, Zhou Z, Wang H (2025) Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis. EClinicalMedicine 88:103464","journal-title":"EClinicalMedicine"},{"issue":"2","key":"13505_CR14","doi-asserted-by":"publisher","first-page":"e70102","DOI":"10.1002\/edm2.70102","volume":"9","author":"AR Bilal","year":"2026","unstructured":"Bilal AR, Ibrahim M, Arfin SMW, Bilal AR, Balach R, Qureshi S, Gaba H, Collins P, Ahmed R, Waqas SA (2026) Efficacy and safety of glucagon-like peptide-1 receptor agonists following bariatric surgery: a systematic review and meta-analysis. Endocrinol Diabetes Metab 9(2):e70102","journal-title":"Endocrinol Diabetes Metab"},{"issue":"1","key":"13505_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00423-025-03831-4","volume":"410","author":"YW Tan","year":"2025","unstructured":"Tan YW, Shang M, Davis S, Gananadha S (2025) GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome improvement: a systematic review and meta-analysis. Langenbecks Arch Surg 410(1):295","journal-title":"Langenbecks Arch Surg"},{"key":"13505_CR16","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/oby.23736","volume":"31","author":"N Murvelashvili","year":"2023","unstructured":"Murvelashvili N, Xie L, Schellinger JN et al (2023) Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence. Obesity (Silver Spring) 31:1280\u20131289","journal-title":"Obesity (Silver Spring)"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13505-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-13505-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13505-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:36:18Z","timestamp":1791477378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-13505-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":16,"alternative-id":["13505"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-13505-x","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"24 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Pamela Jeske, Dr. Julia Roleder , Dr. Kinga Zastawna, Prof. \u0141ukasz Krokowicz and Dr. Krzysztof Szmyt\u00a0 have no conflicts of interest or financial ties to disclose.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}